SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001193125-18-025692
Filing Date
2018-01-30
Accepted
2018-01-30 17:12:56
Documents
6

Document Format Files

Seq Description Document Type Size
1 SC TO-C d521944dsctoc.htm SC TO-C 23058
2 EX-99.1 d521944dex991.htm EX-99.1 77162
3 GRAPHIC g521944g0130104545375.jpg GRAPHIC 4208
4 GRAPHIC g521944g0130104545734.jpg GRAPHIC 2798
5 GRAPHIC g521944g09l55.jpg GRAPHIC 3934
6 GRAPHIC g521944g21c65.jpg GRAPHIC 4725
  Complete submission text file 0001193125-18-025692.txt   124100
Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Filed by) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2834 Pharmaceutical Preparations

Mailing Address TECHNOLOGIEPARK 21 ZWIJNAARDE GHENT C9 9052
Business Address TECHNOLOGIEPARK 21 ZWIJNAARDE GHENT C9 9052 003292620000
Ablynx NV (Subject) CIK: 0001617582 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C9 | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-90201 | Film No.: 18560011
SIC: 2836 Biological Products, (No Diagnostic Substances)